MEDICAL IP vs TeraRecon (2026)
One of these produces the measurement and the other distributes measurements produced by others. MEDICAL IP does segmentation and quantification, one capability underlying a broad portfolio, with one of the widest multi jurisdiction regulatory footprints in this index and strong published validation. TeraRecon is the advanced visualisation platform installed at roughly nineteen hundred sites, vendor independent, with a marketplace so a health system integrates once rather than per algorithm. They fit together rather than compete, and the useful observation is that a marketplace imposes no published performance requirement on what it hosts, so the diligence a hospital skips at integration returns per algorithm, including on the segmentation everything else is derived from.
- Segmentation and quantification is one capability underneath a broad portfolio, evidenced across modalities and body regions rather than claimed.
- One of the broadest multi jurisdiction regulatory portfolios in the index, built steadily over a decade.
- Regulatory classification does real work in place of vendor disclosure, since the cleared scope constrains what the outputs may be used for.
- The installed advanced visualisation base across roughly nineteen hundred clinical sites is the distribution asset, independent of any scanner or archive vendor.
- The marketplace model lets a health system run many partner algorithms through one platform rather than integrating each separately.
- It holds an independent certification in its own name with third party recognition behind the platform.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MEDICAL IP and TeraRecon are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | MEDICAL IP | TeraRecon |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2015 | Not recorded |
| Headquarters | Seoul, South Korea | Cambridge, Massachusetts |
| Website | medicalip.com | terarecon.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards MEDICAL IP its top capability grade on several axes, including AI Centrality, Clinical and Operational Evidence and FDA and Regulatory Status. Set against TeraRecon, MEDICAL IP grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards TeraRecon its top capability grade on EHR and Interoperability Depth and Setting and Specialty Coverage. Set against MEDICAL IP, TeraRecon grades higher on Model Supply Chain Disclosure, Security Certifications and Trust Center and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose MEDICAL IP or TeraRecon?
On the axes where the AI Health Index separates them, MEDICAL IP grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence, and TeraRecon grades higher on Model Supply Chain Disclosure, Security Certifications and Trust Center and EHR and Interoperability Depth. MEDICAL IP leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do MEDICAL IP and TeraRecon differ most?
The widest separation the AI Health Index records between MEDICAL IP and TeraRecon is on AI Centrality, where MEDICAL IP grades A and TeraRecon grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do MEDICAL IP and TeraRecon grade the same?
The AI Health Index grades MEDICAL IP and TeraRecon the same on several axes, including Autonomy and Oversight Model, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have MEDICAL IP and TeraRecon not disclosed?
At the last review, at least one of MEDICAL IP and TeraRecon published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.
One vendor makes measurements and the other distributes other people's, which is the structural relationship worth seeing: quantification output is only as reliable as the segmentation underneath it, and a platform that hosts algorithms imposes no published performance requirement on them.
Neither publishes a subgroup or population performance analysis, and for segmentation that gap has a specific shape since anatomical variation across body habitus and age directly affects boundary accuracy. Neither publishes pricing, and MEDICAL IP publishes no hosting, residency or data handling terms.